Recipharm Secures Vaccine Manufacturing Deal
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
January 28, 2022
by contractpharma
Recipharm streamlines operations by selling oral solid dosage manufacturing site
Astrea Pharma will be the new owner of the facility at Fontaine-lès-Dijon.
January 14, 2022
by CPhIonline
Recipharm Sells Fontaine-lès-Dijon site to Astrea
Astrea is a newly established CDMO focused on small molecule oral solid and aseptic dosages.
January 11, 2022
by contractpharma
Pharmaron Acquires API Manufacturing Facility in UK from Recipharm
Continues to strengthen global chemistry and manufacturing capabilities and capacities.
January 11, 2022
by contractpharma
Lyophilisation technology improving thermal stability and reducing cycle times, says Recipharm expert
Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm.
December 2, 2021
by CPhIonline
Recipharm expands its analytical services offering in India
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions
August 26, 2021
by cphi-online
Recipharm Invests in Fill Finish Capacity
New facility in Uttarakhand, India will increase capacity to 1 billion sterile units per year.
July 19, 2021
by contractpharma
Recipharm to Build New Fill-Finish Facility in Morocco
Investment of around $500M by the Moroccan Government to establish capacity and capability for the manufacturing of vaccines and biotherapeutics.
July 7, 2021
by contractpharma
Recipharm selected to operate new fill/finish facility in Morocco
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
July 7, 2021
by cphi-online
Recipharm and Medspray Complete Joint Venture
Recipharm AB, a contract development and manufacturing organization (CDMO), and Medspray BV, a manufacturer of high tech spray nozzles, have completed a previously announced joint venture and established Resyca BV.
February 9, 2021
by contractpharma
Recipharm, Medspray Launch Resyca JV
Recipharm and Medspray, a manufacturer of high-tech spray nozzles, have established Resyca BV, a joint venture to develop and exploit the softmist spray nozzle technology for pharmaceutical applications.
February 2, 2021
by contractpharma
Recipharm Signs Manufacturing Deal with Enzymatica
Recipharm, a contract development and manufacturing organization (CDMO), and Enzymatica, a Swedish life science company specializing in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme.
January 22, 2021
by contractpharma